Throughout 2011 and 2012, a wave of generic versions for several top-selling drugs will roll out as brand-name prescriptions go off patent.
According to the Associated Press, the magnitude of this wave of expiring drugs patents is unprecedented. [See Drug prices to plummet]
Sales for these drugs is more than $250 billion annually, and it's expected that generic competition will "decimate sales of the brand-name drugs and slash the cost to patients and companies that provide health benefits."
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
